CORMORANT ASSET MANAGEMENT, LLC Information

200 CLARENDON STREET, BOSTON, Massachusetts, 02116, (617) 848-3429

Report Date: 09/30/2015

Position Statistics

Total Positions 86
New Positions 8
Increased Positions 19
Decreased Positions 6
Positions with Activity 25
Sold Out Positions 1
Total Mkt Value (in $ millions) 697

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.78%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 68.48%
Services
Technology
Transportation
Utilities

86 Positions as of 09/30/2015

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
APTOSE BIOSCIENCES INC COM NEW 3,127 New 1,081,867
ACELRX PHARMACEUTICALS INC COM 3,052 New 850,000
EPIRUS BIOPHARMACEUTICALS INC COM 2,833 New 896,600
ATARA BIOTHERAPEUTICS INC COM 2,826 1,884 200 150,000
LION BIOTECHNOLOGIES INC COM 2,714 New 499,815
CELYAD SA ADR 2,624 New 75,000
ARRAY BIOPHARMA INC COM 2,567 New 850,000
EPIZYME INC COM 2,553 New 266,250
ZYNERBA PHARMACEUTICALS INC COM 2,254 2,254 New 356,600
SANGAMO BIOSCIENCES INC COM 2,155 New 361,000
IMMUNE DESIGN CORP COM 2,066 New 189,000
GLYCOMIMETICS INC COM 2,029 New 458,955
REGENXBIO INC COM 1,961 1,961 New 156,741
KARYOPHARM THERAPEUTICS INC COM 1,794 New 300,987
AQUINOX PHARMACEUTICALS INC COM 1,767 -1,530 (46.41) 150,000
VERSARTIS INC COM 1,646 New 170,000
AVEO PHARMACEUTICALS INC COM 1,588 New 1,587,715
DICERNA PHARMACEUTICALS INC COM 1,548 New 245,000
BLUEPRINT MEDICINES CORP COM 1,525 New 100,000
OVASCIENCE INC COM 1,369 New 252,180


Latest News Headlines

View All Latest Headlines
Create your free portfolio